EE208 A Total Cost of Care Analysis of Immune-Oncology (IO) Treatments for Unresectable Hepatocellular Carcinoma (uHCC): A Canadian Payer Perspective
Abstract
Authors
J. Sah V. Genestier L. Qin
J. Sah V. Genestier L. Qin
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now